Clinical Trials Browser

Limited Stage Small Cell Lung Cancer × Immunotherapy × 90 days × Clear all

NCT06943235 2026-02-11

Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in the Treatment of Limited-stage Small Cell Lung Cancer (LS-SCLC)

Phase 2 Recruiting

Limited Stage Small Cell Lung Cancer